Skip to content

ASNDASCENDIS PHARMA A/S

CUSIP K08588103 · common stock

5 tracked investors held ASCENDIS PHARMA A/S (ASND) at the end of Q3 2026, worth $2.6B in total. The largest holder was RA Capital Management, with 23.5% of its portfolio. 2 investors opened new positions this quarter, including Joel Greenblatt.

Holders · Q3 2026
5
New holders
2
Value held
$2.6B
Quarter-end price (est.)
$227.83

Investors holding ASND · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
23.50%10,281,496$2.3BHOLD
Perceptive Advisors
Perceptive Advisors LLC
3.86%971,521$221.3MREDUCE-16.5%
Joel Greenblatt
Gotham Asset Management, LLC
0.03%58,816$13.4MNEW
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.28%28,604$6.5MHOLD
Polen Capital Management
Polen Capital Management LLC
0.05%21,860$5MNEW

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Ron Baron0.00%1,500$400.1KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026521$2.6B$227.83
Q2 2026440$3.1B$266.72